GlassScriptPhysician profile
Pierre De Delva
NPI 1043294432
$71,179.86
in general payments reported to CMS, 2019-2025
27 companies · $16K in 2025
The $16K reported for 2025 was more than what 92% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,554 · 2020: $279 · 2021: $3,368 · 2022: $18K · 2023: $9,289 · 2024: $20K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $32K · Food and Beverage: $4,617 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Consulting Fee: $2,954 · Travel and Lodging: $1,933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $32,000.00 |
| Food and Beverage | $4,616.81 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Consulting Fee | $2,953.50 |
| Travel and Lodging | $1,933.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $51,138.37 | 2019-2025 | Da Vinci Surgical System |
| Genentech USA, INC. | $9,325.80 | 2022-2024 | Tecentriq |
| Astrazeneca Pharmaceuticals LP | $6,515.17 | 2021-2025 | Tagrisso, Onglyza, Imfinzi |
| Medtronic, INC. | $1,533.78 | 2022-2024 | Signia, Illumisite |
| Boston Scientific Corporation | $429.19 | 2022-2025 | Agile Esophageal, Enroute Transcarotid Neuroprotection System |
| Ethicon INC. | $393.80 | 2019 | |
| Atricure, INC. | $340.53 | 2020-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Zimmer Biomet Holdings, INC. | $290.58 | 2019 | |
| Kls-Martin L.P. | $185.84 | 2019-2022 | |
| On Target Laboratories, INC | $185.68 | 2025 | Cytalux |
| Veran Medical Technologies, INC. | $119.90 | 2019 | |
| Amgen INC. | $117.94 | 2019-2025 | Imdelltra (Amg757) |
| Caris Mpi, INC. | $108.70 | 2025 | Mi Cancer Seek |
| Genentech, INC. | $104.76 | 2023-2024 | Tecentriq, Alecensa |
| Baxter Healthcare | $86.40 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $45.40 | 2025 | Irrisept |
| Merck Sharp & Dohme LLC | $36.53 | 2019 | |
| Becton, Dickinson and Company | $29.78 | 2019 | |
| Mirati Therapeutics, INC. | $27.23 | 2023 | Krazati |
| Mauna Kea Technologies, INC. | $26.63 | 2024 | |
| Janssen Biotech, INC. | $25.51 | 2025 | Rybrevant |
| Edwards Lifesciences Corporation | $23.19 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Tela Bio, INC. | $22.55 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Pacira Pharmaceuticals Incorporated | $22.00 | 2022 | |
| Novocure INC. | $17.50 | 2025 | Optune Lua (Novottf-200t) |
| Smith+Nephew, INC. | $13.63 | 2022 | |
| Abbvie INC. | $13.47 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pierre De Delva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.